Odense Universitetshospital (Site 0302)

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Childhood cancers
• Neuroendocrine tumours
• Pancreatic cancer

Running trials

• Recruiting

  Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)

  NCT04924075· Phase 2· Merck Sharp & Dohme LLC· Source

  Contact: Toll Free Number